These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17048473)

  • 1. Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery.
    Chavanpatil MD; Khdair A; Panyam J
    J Nanosci Nanotechnol; 2006; 6(9-10):2651-63. PubMed ID: 17048473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles for drug delivery: review of the formulation and process difficulties illustrated by the emulsion-diffusion process.
    Moinard-Checot D; Chevalier Y; Briançon S; Fessi H; Guinebretière S
    J Nanosci Nanotechnol; 2006; 6(9-10):2664-81. PubMed ID: 17048474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into cellular uptake of nanoparticles.
    Kafshgari MH; Harding FJ; Voelcker NH
    Curr Drug Deliv; 2015; 12(1):63-77. PubMed ID: 25146441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric nanostructures for drug delivery applications based on Pluronic copolymer systems.
    Xiong XY; Tam KC; Gan LH
    J Nanosci Nanotechnol; 2006; 6(9-10):2638-50. PubMed ID: 17048472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
    van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blood-brain barrier and brain drug delivery.
    Koziara JM; Lockman PR; Allen DD; Mumper RJ
    J Nanosci Nanotechnol; 2006; 6(9-10):2712-35. PubMed ID: 17048477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances.
    Xu S; Olenyuk BZ; Okamoto CT; Hamm-Alvarez SF
    Adv Drug Deliv Rev; 2013 Jan; 65(1):121-38. PubMed ID: 23026636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures.
    Murugan K; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Int J Nanomedicine; 2015; 10():2191-206. PubMed ID: 25834433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis.
    Gupta AK; Berry C; Gupta M; Curtis A
    IEEE Trans Nanobioscience; 2003 Dec; 2(4):255-61. PubMed ID: 15376916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of drug and nutritional components in nano-engineered form to increase delivery ratio and reduce current inefficient practice.
    Valtcheva-Sarker RV; O'Reilly JD; Sarker DK
    Recent Pat Drug Deliv Formul; 2007; 1(2):147-59. PubMed ID: 19075882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular uptake and intracellular degradation of poly(alkyl cyanoacrylate) nanoparticles.
    Sulheim E; Baghirov H; von Haartman E; Bøe A; Åslund AK; Mørch Y; Davies Cde L
    J Nanobiotechnology; 2016 Jan; 14():1. PubMed ID: 26743777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.
    Kiriyama A; Iga K; Shibata N
    Ther Deliv; 2013 Oct; 4(10):1261-78. PubMed ID: 24116911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan nanoparticles for oral drug and gene delivery.
    Bowman K; Leong KW
    Int J Nanomedicine; 2006; 1(2):117-28. PubMed ID: 17722528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel drug delivery system by surface modified magnetic nanoparticles.
    Takeda S; Terazono B; Mishima F; Nakagami H; Nishijima S; Kaneda Y
    J Nanosci Nanotechnol; 2006; 6(9-10):3269-76. PubMed ID: 17048546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The smart targeting of nanoparticles.
    Friedman AD; Claypool SE; Liu R
    Curr Pharm Des; 2013; 19(35):6315-29. PubMed ID: 23470005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles in drug delivery: past, present and future.
    Couvreur P
    Adv Drug Deliv Rev; 2013 Jan; 65(1):21-3. PubMed ID: 22580334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
    Liu Y; Miyoshi H; Nakamura M
    Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly organized nanostructures for brain drug delivery--new hope or just a fad?
    Labuzek K; Gorki K; Jaroszek H; Jarzabek K; Gabryel B; Okopien B
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1271-85. PubMed ID: 24040789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development.
    Wong TW; Dhanawat M; Rathbone MJ
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1419-34. PubMed ID: 24960192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of polymeric nanostructure shape on drug delivery.
    Venkataraman S; Hedrick JL; Ong ZY; Yang C; Ee PL; Hammond PT; Yang YY
    Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1228-46. PubMed ID: 21777633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.